Neogen (NEOG) Property, Plant & Equipment (Net) Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Neogen | 1.94 Bn | 1.78 Bn | 99.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 27.64% |
| Nov 30, 2025 | 31.73% |
| Aug 31, 2025 | 33.82% |
| May 31, 2025 | 33.94% |
| Feb 28, 2025 | 33.13% |
| Nov 30, 2024 | 32.12% |
| Aug 31, 2024 | 31.98% |
| May 31, 2024 | 29.93% |
| Feb 29, 2024 | 28.92% |
| Nov 30, 2023 | 27.01% |
| Aug 31, 2023 | 24.85% |
| May 31, 2023 | 22.16% |
| Feb 28, 2023 | 17.86% |
| Nov 30, 2022 | 17.25% |
| Aug 31, 2022 | 13.84% |
| May 31, 2022 | 12.36% |
| Feb 28, 2022 | 11.42% |
| Nov 30, 2021 | 12.68% |
| Aug 31, 2021 | 12.70% |
| May 31, 2021 | 12.93% |
| Feb 28, 2021 | 13.55% |
| Nov 30, 2020 | 10.06% |
| Aug 31, 2020 | 10.33% |
| May 31, 2020 | 12.08% |
| Feb 29, 2020 | 12.48% |
| Nov 30, 2019 | 12.35% |
| Aug 31, 2019 | 11.97% |
| May 31, 2019 | 12.28% |
| Feb 28, 2019 | 13.93% |
| Nov 30, 2018 | 14.09% |
| Aug 31, 2018 | 15.27% |
| May 31, 2018 | 16.30% |
| Feb 28, 2018 | 16.76% |
| Nov 30, 2017 | 16.42% |
| Aug 31, 2017 | 15.59% |
| May 31, 2017 | 15.58% |
| Feb 28, 2017 | 15.63% |
| Nov 30, 2016 | 13.96% |
| Aug 31, 2016 | 14.15% |
| May 31, 2016 | 19.61% |